Form 4: Hologic Executive Jan Verstreken Reports Stock Transaction
SEC Form 4 Filing
Hologic's Group President, International, Jan Verstreken, disposed of 630 shares of common stock to cover tax obligations related to vested restricted stock units.
Summary
- Jan Verstreken, Group President, International at Hologic Inc., reported a transaction involving the company's common stock.
- On November 14, 2024, Mr. Verstreken disposed of 630 shares of Hologic common stock.
- The shares were disposed of at a price of $77.54 per share.
- This transaction was to cover tax obligations related to the settlement of restricted stock units that had vested.
- Following the transaction, Mr. Verstreken directly owns 103,814 shares of Hologic common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any significant positive or negative sentiment.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly traded companies.
- The sale of shares to cover tax obligations is a standard practice for executives receiving stock-based compensation.
- The number of shares sold and the price are within the typical range for such transactions.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Date of the stock transaction. |
| 11/18/2024 | Date of the signature on the form. |
Keywords
Hologic, Stock Transaction, Form 4, Jan Verstreken, Executive Stock, Restricted Stock Units, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.